Pregnancy Testing Market Size, Share, Industry, Forecast and outlook (2023-2030)

Pregnancy Testing Market is segmented By Product Type (Pregnancy test kits (Strips/dipsticks and cards, Digital devices, Midstream kits, Cassettes), Fertility test kits (Line indicator kits, Digital devices)), By Test Type (hCG Blood, hCG Urine, FSH Urine, LH Urine), By Distribution channel (Online Sales, Gynecology/ Fertility Clinics, Pharmacies/Drugstores, Hypermarkets, and Supermarkets), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030.

Pregnancy Testing Market Overview

Pregnancy Testing Market size was valued USD million in 2021 and is estimated to reach USD million by 2030, growing at a CAGR of 5% during the forecast period (2023-2030). 

Pregnancy test kits are medical devices that detect early signs of pregnancy in women. The device detects a small amount of HCG (human chorionic gonadotropin, female pregnancy hormone) that grows in the human body during the first few weeks of development. The level of HCG in the blood doubles every 2 to 3 days during the first days of pregnancy, which indicates that the pregnancy is progressing. Thus, the presence of HCG above a certain level indicates pregnancy.

As per DataM Intelligence, Pregnancy Testing Market study analysis offers an in-depth outlook on the market containing quantitative and qualitative data. It gives an outlook and forecast of the global market based on market segmentation. It also provides global Pregnancy Testing Market size, and growth, along with the latest trends, opportunities, and forecast till 2029 for the global market with esteem to major countries such as the United States, Canada, Brazil, Germany, Italy, Spain, United Kingdom, Russia, European countries, United Arab Emirates, Saudi Arabia, South Africa, Japan, China, India, South Korea, Australia, and rest of the countries over the globe.

Among all regions, the North American region is expected to hold the largest share of the global market over the forecast period. Pregnancy Testing Market in the United States and Canada produces the utmost share. Whereas the European Pregnancy Testing Market is projected to continue its presence globally during the period of 2023- 2030.

Pregnancy Testing Market Scope

To Know More Insights - Download Sample

Pregnancy Testing Market Dynamics

The growing prevalence drives global pregnancy testing market growth for gynecological issues and fertility disorders, growing demand for self-detecting pregnancy kits, increasing government support for the use of pregnancy tests, technological advancements in pregnancy test kits, increase in unintended pregnancy rate as well as adolescent pregnancy rate and increase in the number of launches of new products.

Technological Advancements in Pregnancy Testing Kits are expected to drive market growth.

Manufacturers of pregnancy and fertility rapid tests are providing technologically advanced products that are more sensitive to improve the experience of consumers. For instance, pregnancy rapid tests available 10 years ago were designed to show results at a concentration above 25IU/L in a sample. The introduction of monoclonal antibody technology for rapid diagnosis improved the sensitivity to 10 IU/L, which enabled early pregnancy detection. Moreover, manufacturers also focus on providing user-friendly and value-added features to customers to differentiate their product offerings. The introduction of digital devices, such as Clearblue Easy, has rapidly adopted home pregnancy and fertility test kits. Fairhaven Health LLC provides OvaCue, a fertility monitor that can connect to a smartphone app. It helps predicts the ovulation time or fertility window, thus improving the chances of conceiving. Therefore, constant technological advancements in pregnancy testing kits are expected to propel the market over the forecast period.

Restraint:

However, lack of awareness, and inaccurate results are hampering the market. Most of the test kits claim that they are 99% accurate. But, there is a possibility of false results, as the accuracy mainly depends on factors like the brand and improper usage.

Industry Analysis

The pregnancy testing market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

Pregnancy Testing Market Segment Analysis

Pregnancy test kits segment is expected to hold the largest market share in the pregnancy testing market.

Pregnancy test kits are further sub-segmented into Strips/dipsticks and cards, Digital devices, Midstream kits, and Cassettes. The segment benefits because pregnancy test kits sense tiny amounts of HCG (Human Chorionic Gonadotrophin; female pregnancy hormone), which increases during the early stages of pregnancy in the female body. The pregnancy test kit detects the pregnancy hormone, human chorionic gonadotrophin (hCG), in the urine or serum. The test can be taken on the first day of the missing period. Continuous technological advancement in pregnancy test kits is a major factor expected to drive the market's growth. The demand for pregnancy test kits is increasing substantially owing to increasing incidences of unplanned pregnancy globally, driving the global pregnancy testing market. The introduction of newer products is an ongoing trend in the pregnancy testing market. For instance, On June 9, 2022, Mylab Discovery Solutions entered the female healthcare segment with the launch of PregaScreen. This home pregnancy testing kit enables women to self-diagnose their pregnancy status. Priced at just INR 55, PregaScreen offers a convenient, easy-to-use and reliable testing method for women to confirm their pregnancy after missing their first period. This rapid at-home test kit provides results with an accuracy of 99.99 percent in minutes and can be purchased over the counter at local pharmacies across India. Each kit consists of a pregnancy stick and a dropper. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

Pregnancy Testing Market Geographical Share

North American region is expected to hold the largest market share in the global pregnancy testing market.

The North American region accounted for the largest market share in 2021. The increased awareness among women leads to the increased demand for self-detecting pregnancy kits, growing fertility disorders, increased unplanned pregnancy rates, and favorable government initiatives related to family planning. The unplanned pregnancy rate in the US is expected to boost the market. For instance, according to a research study by Amanda Black et al., published in the Journal of Obstetrics and Gynecology Canada in May 2019, there were more than 39,000 unintended pregnancies (UPs) among Canadian youth annually. Market players pursue strategies such as product launches, developments, collaborations, acquisitions, and expansions to increase market share. For instance, in December 2020, Church & Dwight Co., Inc. completed the acquisition of Matrixx Initiatives, Inc., a consumer health company engaged in developing and commercializing products that utilize unique delivery systems. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Pregnancy Testing Market Comapnies

Major key players in the pregnancy testing market are Abbott Laboratories, EKF Diagnostics Holdings plc, BioMérieux SA, Atlas Medical, Quidel Corporation, BIOSYNEX SA, Prestige Brands Holdings, Swiss Precision Diagnostics (SPD) GmbH, Piramal Enterprises, NG BIOTECH SAS.

Swiss Precision Diagnostics:

Overview:

Swiss Precision Diagnostics (SPD) was formed as a joint venture between Procter & Gamble (P&G) and Alere (now a part of the Abbott group, since October 2017) to create, using its parent companies complementary strengths, one of the world’s foremost organizations in consumer diagnostics. Alere (a wholly owned subsidiary of Abbott) is among the world’s leading providers of innovative diagnostic products, renowned for their proven reliability in the professional management of women’s health and chronic and infectious disease. SPD is currently a leading home pregnancy and fertility/ovulation test supplier. The company has a strong focus on women’s reproductive health, and our goals are in the continuing supply of diagnostic products which are accurate, simple and affordable.

­Product Portfolio:

Clearblue: The Clearblue range of diagnostic products is for women wanting to know more about their fertility and pregnancy status. These include pregnancy tests that give clear and accurate results and advanced fertility and ovulation tests to help identify the most fertile days of the reproductive cycle.

The global pregnancy testing market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.